Urinary Tract Infection Clinical Trials

85 recruitingLast updated: July 25, 2026

There are 85 actively recruiting urinary tract infection clinical trials across 39 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1. Top locations include Seattle, Washington, United States, Houston, Texas, United States, Hvidovre, Denmark. Updated daily from ClinicalTrials.gov.


Urinary Tract Infection Trials at a Glance

85 actively recruiting trials for urinary tract infection are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Seattle, Houston, and Hvidovre. Lead sponsors running urinary tract infection studies include Atlantic Health System, Baylor College of Medicine, and Centre Hospitalier Intercommunal Creteil.

Browse urinary tract infection trials by phase

Treatments under study

About Urinary Tract Infection Clinical Trials

Looking for clinical trials for Urinary Tract Infection? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Urinary Tract Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Urinary Tract Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 85 trials

Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

Radiation CystitisUrinary Tract Infection (Diagnosis)
Rachel A. Moses100 enrolled1 locationNCT07368647
Recruiting
Phase 4

Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children

Complicated urinary tract infectionInfectionPediatric Infectious Disease
Murdoch Childrens Research Institute452 enrolled7 locationsNCT04876131
Recruiting
Not Applicable

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

Urinary Tract Infections
University Hospitals Cleveland Medical Center47 enrolled1 locationNCT06976125
Recruiting
Not Applicable

Antibiotic Irrigation and Suction Ureteral Access Sheath in RIRS

Urinary Tract InfectionsUrolithiasisKidney Calculi
Hitit University180 enrolled2 locationsNCT07655050
Recruiting
Phase 2

A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection

Chronic Urinary Tract Infection
University College, London192 enrolled4 locationsNCT07202949
Recruiting

Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)

Urinary Tract InfectionsAntiobiotic StewardshipEmerging Infectious Disease
Centre Hospitalier Intercommunal Creteil330 enrolled3 locationsNCT07559318
Recruiting
Not Applicable

Double Voiding and Post-transplant UTI

Kidney Transplant; ComplicationsUrinary Tract Infections
Weill Medical College of Cornell University438 enrolled1 locationNCT05711446
Recruiting
Phase 2

Antibiotic Prophylaxis for Neurogenic Bladder Botox

Neurogenic BladderPost-operative Urinary Tract Infections
University of Alberta160 enrolled1 locationNCT04791579
Recruiting
Phase 4

Betadine vs Sterile Water for Periurethral Preparation

Urinary Tract Infection BacterialCatherization
University of Louisville148 enrolled2 locationsNCT07044726
Recruiting
Phase 2

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis

Complicated urinary tract infectionAcute Pyelonephritis
Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)66 enrolled26 locationsNCT06672978
Recruiting
Not Applicable

Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients

Kidney DiseasesUrologic DiseasesUrinary Tract Infections+3 more
Institute of Spa and Balneology, public research institution150 enrolled1 locationNCT07435844
Recruiting
Phase 1Phase 2

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Urinary Tract Infections
GlaxoSmithKline448 enrolled8 locationsNCT06702449
Recruiting
Not Applicable

Using Virtual Reality to Improve Medical Training

Urinary tract infection (UTI)Geriatric syndromesDisability Physical+3 more
Ohio University100 enrolled1 locationNCT07542834
Recruiting

Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness

Chronic Obstructive Pulmonary Disease (COPD)PneumoniaInfection+6 more
National University Hospital, Singapore220 enrolled1 locationNCT07536035
Recruiting
Not Applicable

Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units

Urinary tract infection (UTI)Infection, HospitalAntimicrobial+2 more
Hospital Israelita Albert Einstein5,000 enrolled12 locationsNCT07233837
Recruiting

Febrile Infants Swedish Study

Serious Bacterial InfectionSepsisBacteremia+4 more
Region Skane2,000 enrolled11 locationsNCT07134751
Recruiting

Effect of Vulvar Re-Antisepsis Before Cystoscopy on Urinary Infections in Laparoscopic Hysterectomy

Postoperative Urinary Tract Infection
Alaattin Karabulut200 enrolled1 locationNCT07232446
Recruiting
Phase 4

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

Urinary Tract Infection
Baylor College of Medicine40 enrolled3 locationsNCT07508124
Recruiting
Phase 2

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

Urinary Tract Infections
Locus Biosciences318 enrolled17 locationsNCT05488340